참고문헌
- Alexius-Lindgren M, Andersson E, Lindstedt I, et al (2014). The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases. Anticancer Res, 34, 3867-73.
- Cho YB, Lee WY, Song SY, et al (2007). Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer. Hum Pathol, 38, 1603-10. https://doi.org/10.1016/j.humpath.2007.03.018
- Clark JC, Thomas DM, Choong PF, et al (2007). RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev, 26, 675-83. https://doi.org/10.1007/s10555-007-9093-8
- Furumoto K, Arii S, Mori A, et al (2001). RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs. Hepatology, 33, 189-95. https://doi.org/10.1053/jhep.2001.21048
- Jeon HW, Lee YM (2010). Inhibition of histone deacetylase attenuates hypoxia-induced migration andinvasion of cancer cells via the restoration of RECK expression. Mol Cancer Ther, 9, 1361-70. https://doi.org/10.1158/1535-7163.MCT-09-0717
- Khaderi S, Guiteau J, Cotton RT, et al (2014). Role of liver transplantation in the management of hepatoblastoma in the pediatric population. World J Transplant, 4, 294-8. https://doi.org/10.5500/wjt.v4.i4.294
- Kimura T, Okada A, Yatabe T, et al (2010). RECK is up-regulated and involved in chondrocyte cloning in humanosteoarthritic cartilage. Am J Pathol, 176, 2858-67. https://doi.org/10.2353/ajpath.2010.091003
- Kremer N, Walther AE, Tiao GM (2014). Management of hepatoblastoma: an update. Curr Opin Pediatr, 26, 362-9. https://doi.org/10.1097/MOP.0000000000000081
- Martinez-Criado Y, Cabello R, Fernandez-Pineda I, et al (2013). Study of the expression of neural stem cell markers in neuroblastoma tumor samples and correlation with prognostic factors. Cir Pediatr, 26, 112-8.
- Morandi F, Corrias MV, Pistoia V (2015). Evaluation of bone marrow as a metastatic site of human neuroblastoma. Ann N Y Acad Sci, 1335, 23-31. https://doi.org/10.1111/nyas.12554
- Peters H, Augusto TM, Bruni-Cardoso A, et al (2010). RECK expression in the rat ventral prostate: response to castration involves a balance between epithelial and stromal expression. Anat Rec (Hoboken), 293, 993-7. https://doi.org/10.1002/ar.21140
- Verma S, Kesh K, Ganguly N, et al (2014). Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants. World J Biol Chem, 5, 355-76. https://doi.org/10.4331/wjbc.v5.i3.355
- Wang JL, Wu DW, Cheng ZZ, et al (2014). Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC). Asian Pac J Cancer Prev, 15, 4865-9. https://doi.org/10.7314/APJCP.2014.15.12.4865
- Xie J, Tan ZH, Tang X, et al (2014). MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. World J Gastroenterol, 20, 17439-47. https://doi.org/10.3748/wjg.v20.i46.17439
- Yanez Y, Grau E, Rodriguez-Cortez VC, et al (2015). Two independent epigenetic biomarkers predict survival in neuroblastoma. Clin Epigenetics, 7, 16. https://doi.org/10.1186/s13148-015-0054-8
- Yang L, Li N, Wang S, et al (2014). Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 15, 4823-7. https://doi.org/10.7314/APJCP.2014.15.12.4823
- Zhang Y, Zhang WL, Huang DS, et al (2013). Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study. Asian Pac J Cancer Prev, 14, 4583-9. https://doi.org/10.7314/APJCP.2013.14.8.4583
피인용 문헌
- Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) vol.07, pp.12, 2016, https://doi.org/10.4236/jct.2016.712091
- PKCζ, MMP-2 and MMP-9 expression in lung adenocarcinoma and association with a metastatic phenotype vol.16, pp.6, 2017, https://doi.org/10.3892/mmr.2017.7634
- The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression vol.19, pp.2, 2018, https://doi.org/10.3390/ijms19020450